Risk reduction for small cell cancer of the ovary, hypercalcemic type in prepubertal patient: A clinical and bioethical perspective
John Vu(Mayo Clinic), Amanika Kumar(Mayo Clinic), Asma Chattha(Mayo Clinic), Ellen J. Case(Mayo Clinic in Florida), Myra Wick, Whitney S. Thompson(Mayo Clinic), Christopher A. Collura(Mayo Clinic), Denise B. Klinkner(Mayo Clinic)
Cited by 4
Related Papers
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2020|507
Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.
|The Journal of Experimental Medicine|1984|483
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2016|293